Cognitive impairment and risk of dementia in heart failure: the exuberating role of digoxin
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-025-04457-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Hayder M Al-Kuraishy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq. Hauptthemen laut MEDLINE: Heart Failure, Digoxin, Cognitive Dysfunction, Dementia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 133 Literaturangaben.
Themen: Herzinsuffizienz, Demenz
Abstract (Originalsprache)
Heart failure (HF) is a clinical syndrome with a wide range of presentations due to functional and structural abnormalities of the heart. HF may induce the development of cognitive impairment and increased risk of dementia. HF frequently coexists with cognitive impairments in about 40-60% of elderly patients. In addition, cognitive impairment reduces life quality and increases mortality in patients with HF, signifying a close interrelated relationship between HF and cognitive impairment. Prominently, regional brain hypoperfusion in patients with HF leads to autonomic dysfunction, mood, and cognitive disorders. HF increases the risk of vascular dementia (VD), which refers to cardiogenic dementia. Remarkably, the anti-failure drug digoxin, which is commonly used in the management of HF, affects the development of cognitive impairment and dementia. Numerous studies highlighted the neuroprotective effect of digoxin against the development of cognitive impairment and dementia. Though, the fundamental neuroprotective mechanisms of digoxin against cognitive impairment and dementia are not completely explained. This review seeks to examine the relationship between heart failure and the onset of cognitive impairment and dementia, as well as the role of digoxin in mitigating the adverse impact of heart failure on cognitive function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
- Department of Pharmacology and Toxicology, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.
- Department Biotechnology, College of Applied Sciences, University of Technology, Baghdad, 10066, Iraq. ghassan.m.sulaiman@uotechnology.edu.iq.
- Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim, 51452, Saudi Arabia.
- Department Biotechnology, College of Applied Sciences, University of Technology, Baghdad, 10066, Iraq.
- Jabir Ibn Hayyan Medical University, Kufa, Najaf, 54001, Iraq.
Zitieren
APA
Al-Kuraishy, H. M., Fahad, E. H., Sulaiman, G. M., Mohammed, H. A., Jabir, M. S., Al-Gareeb, A. I., & Albuhadily, A. K. (2025). Cognitive impairment and risk of dementia in heart failure: the exuberating role of digoxin. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04457-5
Vancouver
Al-Kuraishy HM, Fahad EH, Sulaiman GM, Mohammed HA, Jabir MS, Al-Gareeb AI, et al. Cognitive impairment and risk of dementia in heart failure: the exuberating role of digoxin. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04457-5
BibTeX
@article{AlKuraishy2025,
author = {Al-Kuraishy, Hayder M and Fahad, Esraa H and Sulaiman, Ghassan M and Mohammed, Hamdoon A and Jabir, Majid S and Al-Gareeb, Ali I and Albuhadily, Ali K},
title = {Cognitive impairment and risk of dementia in heart failure: the exuberating role of digoxin},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-025-04457-5}
}
EUVIMED